SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Valuation
An SI Board Since February 1999
Posts SubjectMarks Bans Symbol
52157 680 3 CRSP
Emcee:  Biomaven Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
50578As I responded on twitter, it's always possible that an AE like cardiomyopatBiomaven212/21/2018
50577FGEN, speaking of safety data, I've been digging around trying to find studituck312/21/2018
50576>>Citi analyst is still an idiot... That's not nice. But it is TRUE.IRWIN JAMES FRANKEL212/21/2018
50575It was a joke.scaram(o)uche-12/20/2018
50574Deep, deep congratulations. Know it was slow slogging. And.... thanks! Riscaram(o)uche-12/20/2018
50573>>Anybody here follow FGEN?? FGEN? I do recall buying some way back when.Biomaven112/20/2018
50572Yes, I follow FGEN. It remains grossly undervalued, especially when you consideArt Bechhoefer-12/20/2018
50571>> Believe basis is about 7 << Basis is 11 and change. :-(scaram(o)uche-12/20/2018
50570Yes, I've owned the ADRs for years, long enough that the maintenance fees hascaram(o)uche-12/20/2018
50569Anybody here follow FGEN??scaram(o)uche312/20/2018
50568Fibrogen up 7% on Roxadust approval in China, finance.yahoo.comA.J. Mullen-12/19/2018
50567As very amateur-player, my favorites are English and Sicilian am astonished how Miljenko Zuanic-12/18/2018
50566>>it was trying to win a drawn game That could conceivably have been a seBiomaven-12/18/2018
50565thanks for posting it since i don't normally play over computer games. Heresoftware salesperson112/18/2018
50564Indivior Conference Call, indivior.com Current cash is $910m. They plan to launA.J. Mullen-12/18/2018
50563Full disclosure, I have a small investment in Mission Bio. Here's some presA.J. Mullen-12/16/2018
50562Mission Bio Raises $30M to Scale the First-ever Platform Aimed at Predicting andA.J. Mullen-12/16/2018
50561Gilead names new CEO from Roche, wsj.com - AshleyA.J. Mullen-12/14/2018
50560Are you sure this isn't a repeat from The Onion...Ian@SI212/14/2018
50559Parachute use to prevent death and major trauma when jumping from aircraft: randBiotech Jim612/14/2018
50558Anyone following Innate Pharma? Their anti-NKG2A monoclonal (Monalizumab) seems dr_elis-12/14/2018
50557Big pharma is nothing if not conservative and cautious. Doubt they would be talkBiomaven212/13/2018
50556continuing to talk to myself, LOL Precious little green in biotech land this wequidditch-12/13/2018
50555one aspect of corporate culture that is bothersome to me in the AZN bullishness:quidditch-12/13/2018
50554On their call AZN called roxa "an exciting opportunity" and talked aboBiomaven-12/13/2018
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News